ProCE Banner Activity

TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale

Slideset

Download these slides on the evolving treatment landscape of advanced NSCLC with a focus on the rationale for targeting TROP-2 and the potential role of TROP-2-targeting ADCs.

Released: April 25, 2024

Expiration: April 24, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.